Source: Business Wire

Press Release: EYLEA : Global Myocardial Infarction Treatment Market Growth of 3.1% CAGR by 2025 - Analysis, Technologies & Forecasts Report 2016-2025 - Key Vendors: Bayer, Pfizer, Mylan - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Myocardial Infarction Treatment Market Analysis & Trends - Industry Forecast to 2025" report to their offering. The Global Myocardial Infarction Treatment Market is poised to grow at a CAGR of around 3.1% over the forecast period 2015 to 2025. This industry report analyzes the global markets for Myocardial Infarction Treatment across all the given segments on global as well as regional levels presented i

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Eylea is a Private company. Eylea has a revenue of $10M, and 10 employees. Eylea has 1 followers on Owler.